In mid-August, the FDA and Merck announced a new medication approved as an insomnia treatment. Suvorexant is the first drug in its class that’s FDA approved. It is an orexin-receptor antagonist designed to help orexins regulate the sleep-wake cycle.
The FDA has recommended this medication be classified as a Schedule IV controlled substance. The drug will be marketed under the name Belsomra, by the end of the year or early in 2015. Before it can reach the market, the Drug Enforcement Administration, or DEA, must finalize the controlled substance scheduling process. [click to continue…]
The FDA has recently announced the approval of a new drug used to treat relapsing multiple sclerosis. Manufacturer Biogen Idec Inc. announced their peg interferon beta-1a injection, known as Plegridy, received approval as a treatment option for relapsing forms of MS.
By attaching a polyethylene glycol molecule to the interferon beta-1a, it extends the medication’s half life, thus allowing patients to go longer between doses. Their product has a dosing schedule of once every two weeks, while the other two interferon beta-1a products on the market must be administered one to three times a week. [click to continue…]
While most people know October as National Breast Cancer Awareness Month, few also know it is Healthy Lung Month. As a pharmacist, you can help your patients learn more about how to keep their lungs healthy and strong, providing extra education throughout October. [click to continue…]
Recently, the Missouri Department of Mental Health approved pharmacists to step into the role of psychiatric care provider. The decision has created a more efficient community treatment team.
Since community psychiatry involves reaching out to people wherever you find them (at home, in restaurants, even under bridges) to provide care and support, it is difficult to find psychiatrists who want to practice community psychiatry. As such, this allows a pharmacist to step into the role where a psychiatrist is difficult to find. [click to continue…]
Clinical pharmacist Candis Morello serves as the director of San Diego Department of Veterans Affairs (VA) Diabetes Intense Medical Management (DIMM) clinic. With her counseling, veterans with a history of type II diabetes are learning how to improve their condition. [click to continue…]
Photo courtesy of the Drug Enforcement Administration
Do you have unneeded or expired medications lingering around in your home? This Saturday, the Drug Enforcement Administration (DEA) will be hosting its National Drug Take-Back Day to collect unwanted, unneeded, or expired medications free and anonymously.
We at RPh on the Go encourage you to take part in this unique opportunity to safely and legally dispose of unneeded medications such as prescription painkillers and other controlled substance (CS) medications, typically only accepted for disposal with the presence of law enforcement.
More than 4.1 million pounds of unwanted medication have safely been disposed of in previous DEA Take-Back Days in more than 6,000 drop-off locations across the U.S. Check out DEA’s collection site locator, now available online here.
Please contact RPh on the Go Director of Quality Assurance & Compliance Steve Sidell if you have any questions about the DEA Prescription Drug Take-Back Program at firstname.lastname@example.org or at 847.588.7499.